Rusterholtz Thierry, Bollaert Pierre-Edouard, Feissel Marc, Romano-Girard Florence, Harlay Marie-Line, Zaehringer Michel, Dusang Benjamin, Sauder Philippe
Service de Réanimation Médicale, Centre Hospitalier et Universitaire, Strasbourg, France.
Intensive Care Med. 2008 May;34(5):840-6. doi: 10.1007/s00134-008-0998-7. Epub 2008 Jan 23.
To compare continuous positive airway pressure (CPAP) and proportional assist ventilation (PAV) as modes of noninvasive ventilatory support in patients with severe cardiogenic pulmonary edema.
A prospective multicenter randomized study in the medical ICUs of three teaching hospitals.
Thirty-six adult patients with cardiogenic pulmonary edema (CPA) with unresolving dyspnea, respiratory rate above 30/min and/or SpO2 above 90% with O2 higher than 10 l/min despite conventional therapy with furosemide and nitrates.
Patients were randomized to undergo either CPAP (with PEEP 10 cmH2O) or PAV (with PEEP 5-6 cmH2O) noninvasive ventilation through a full face mask and the same ventilator.
The main outcome measure was the failure rate as defined by the onset of predefined intubation criteria, severe arrythmias or patient's refusal. On inclusion CPAP (n=19) and PAV (n=17) groups were similar with regard to age, sex ratio, type of heart disease, SAPS II, physiological parameters (mean arterial pressure, heart rate, blood gases), amount of infused nitrates and furosemide. Failure was observed in 7 (37%) CPAP and 7 (41%) PAV patients. Among these, 4 (21%) CPAP and 5 (29%) PAV patients required endotracheal intubation. Changes in physiological parameters were similar in the two groups. Myocardial infarction and ICU mortality rates were strictly similar in the two groups.
In the present study PAV was not superior to CPAP for noninvasive ventilation in severe cardiogenic pulmonary edema with regard to either efficacy and tolerance.
比较持续气道正压通气(CPAP)和比例辅助通气(PAV)作为重症心源性肺水肿患者无创通气支持模式的效果。
在三家教学医院的医学重症监护病房进行的一项前瞻性多中心随机研究。
36例成年心源性肺水肿(CPA)患者,尽管接受了呋塞米和硝酸盐类药物的常规治疗,但仍存在呼吸困难、呼吸频率高于30次/分钟和/或在吸氧流量高于10升/分钟时血氧饱和度高于90%。
患者被随机分配接受通过全面罩和同一台呼吸机进行的CPAP(呼气末正压10 cmH₂O)或PAV(呼气末正压5 - 6 cmH₂O)无创通气。
主要结局指标为根据预定义的插管标准、严重心律失常或患者拒绝等情况定义的失败率。纳入研究时,CPAP组(n = 19)和PAV组(n = 17)在年龄、性别比例、心脏病类型、简化急性生理学评分II(SAPS II)、生理参数(平均动脉压、心率、血气)、输注硝酸盐和呋塞米的量等方面相似。7例(37%)CPAP患者和7例(41%)PAV患者出现失败情况。其中,4例(21%)CPAP患者和5例(29%)PAV患者需要气管插管。两组生理参数的变化相似。两组的心肌梗死发生率和重症监护病房死亡率严格相似。
在本研究中,对于重症心源性肺水肿患者的无创通气,PAV在疗效和耐受性方面并不优于CPAP。